Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, +251

The Lancet Oncology

First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine +5

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma

Shunji Takahashi, Motohide Uemura, Tomokazu Kimura, +9

Investigational New Drugs

Pinpoint targeted immunosuppression: anti‐CD20/MMF desensitization with anti‐CD25 in successful ABO‐incompatible kidney transplantation without splenectomy

Kazuhide Saito, Yuki Nakagawa, Michihiro Suwa, +7

Xenotransplantation

Immunohistochemical Detection of Intercellular Adhesion Molecule-1 (ICAM-1) and Major Histocompatibility Complex Class I Antigens in Seminoma

Yoshihiko Tomita, Motohiko Kimura, Toshiki Tanikawa, +5

The Journal of Urology

Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes

Kazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura, +6

International Journal of Urology

CORRELATION OF p53 PROTEIN EXPRESSION IN HUMAN UROTHELIAL TRANSITIONAL CELL CANCERS WITH MALIGNANT POTENTIAL AND PATIENT SURVIVAL

Ryusuke Watanabe, Yoshihiko Tomita, Tsutomu Nishiyama, +2

International Journal of Urology

Urinary Bladder CancerUrologyGenitourinary CancerP53 Gene ProductMedicine +8

mRNA and protein expression of p53 mutations in human bladder cancer cell lines

Takashi Kawasaki, Yoshihko Tomita, Ryusuke Watanabe, +3

Cancer Letters

UrologyP53 MutationsProtein ExpressionGenitourinary CancerMedicine +7

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients

M Kimura, Yoshihiko Tomita, Tomoyuki Imai, +5

British Journal of Cancer

UrologyRenal FunctionKidney TransplantGenitourinary CancerMedicine +11

Expression of E-Cadherin and Catenins on Testis Tumor

Toshihiro Saito, Akiyoshi Katagiri, Ryusuke Watanabe, +4

Urologia Internationalis

Tumor BiologyEcd FunctionsMalignant DiseaseNormal GrowthHistopathology +10

Adoptive Immunotherapy of Patients with Metastatic Renal Cell Cancer Using Lymphokine‐Activated Killer Cells, lnterleukin‐2 and Cyclophosphamide: Long‐Term Results

Yoshihiko Tomita, Akiyoshi Katagiri, Kazuhide Saito, +6

International Journal of Urology